companydata.dkcompanydata.dk

NORDIC BIOTECH ADVISORS ApS: Financial statements 2017

CVR: 26123925

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

NORDIC BIOTECH ADVISORS ApS (CVR 26123925) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 3,148,911 and a net result of DKK 85,668 compared with DKK 569,324 the year before. That is a decrease of 15.3% compared with the year before. Equity in the 2017 report amounted to DKK 2,141,753. The solvency ratio was 77.9%.

Gross Profit
DKK 3,148,911
Profit/Loss
DKK 85,668
Equity
DKK 2,141,753
Total Assets
DKK 2,749,105

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-3.1M86K2.1M-
2016-3.7M569K2.1M-
2015-3.6M274K1.5M-
2014-2.8M-162K1.2M-
2013-3.6M9K1.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NORDIC BIOTECH ADVISORS ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

NORDIC BIOTECH ADVISORS ApS: The 2016 annual report is outJun 18, 2017

NORDIC BIOTECH ADVISORS ApS has published its annual report for 2016. Gross profit came to DKK 3,717,818, and the net result was DKK 569,324.

About NORDIC BIOTECH ADVISORS ApS

NORDIC BIOTECH ADVISORS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is registered under the industry Andre aktiviteter i forbindelse med finansielle tjenesteydelser, undtagen forsikring og pensionsforsikring. The company was previously named NEXGEN BIOTECH ApS and NORDIC BIOTECH ApS. The management consists of Florian Schønharting. The board consists of Florian Schønharting and Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS, C. HANSEN INVEST ApS and BVF/Nexgen Biotech, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,273,154 and a net result of DKK 360,368 compared with DKK -572,578 the year before. Equity in the 2025 report amounted to DKK 4,622,219.

Source: annual report 2025, Danish Business Authority